Detalhe da pesquisa
1.
Trajectory of left ventricular ejection fraction in response to therapies in patients with muscular dystrophy.
Echocardiography
; 39(10): 1328-1337, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198087
2.
Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.
Muscle Nerve
; 64(6): 662-669, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590717
3.
Reduced plasmablast frequency is associated with seronegative myasthenia gravis.
Muscle Nerve
; 63(4): 577-585, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33294984
4.
Clinical utility of 12-lead electrocardiogram in evaluating heart disease in patients with muscular dystrophy: Assessment of left ventricular hypertrophy, conduction disease, and cardiomyopathy.
Ann Noninvasive Electrocardiol
; 26(6): e12876, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250701
5.
Label-free proteomic analysis reveals large dynamic changes to the cellular proteome upon expression of the miRNA-23a-27a-24-2 microRNA cluster.
Biochem Cell Biol
; 98(1): 61-69, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31095918
6.
Metabolomic profile overlap in prototypical autoimmune humoral disease: a comparison of myasthenia gravis and rheumatoid arthritis.
Metabolomics
; 16(1): 10, 2020 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31902059
7.
Autonomic involvement in Guillain-Barré syndrome: an update.
Clin Auton Res
; 29(3): 289-299, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30019292
8.
Rituximab in refractory myasthenia gravis: Extended prospective study results.
Muscle Nerve
; 58(3): 452-455, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29742795
9.
Gamunex® in Guillain-Barré Syndrome: A Postmarketing, Retrospective, Observational Study.
Can J Neurol Sci
; 44(6): 711-717, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29391076
10.
AMPA-R Limbic Encephalitis Associated with Systemic Lupus Erythematosus.
Can J Neurol Sci
; 47(5): 709-710, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32279661
11.
Posterior Reversible Encephalopathy Syndrome Due to Chronic Obstructive Pulmonary Disease.
Can J Neurol Sci
; 47(4): 569-571, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32174293
12.
Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open-label extension.
Ann Clin Transl Neurol
; 11(1): 194-206, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38062618
13.
Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series.
Eur Heart J Case Rep
; 7(1): ytad013, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727127
14.
Residual serum fibrinogen as a universal biomarker for all serotypes of Myasthenia gravis.
Sci Rep
; 13(1): 21229, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38040826
15.
Prognostic Utility of Cardiovascular Magnetic Resonance-Based Phenotyping in Patients With Muscular Dystrophy.
J Am Heart Assoc
; 12(21): e030229, 2023 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37929714
16.
Low Prevalence of Cardiomyopathy in Patients with Mitochondrial Disease and Neurological Manifestations.
J Cardiovasc Dev Dis
; 9(7)2022 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877583
17.
Rituximab in Myasthenia Gravis - Where do we stand?
Expert Opin Biol Ther
; 21(8): 1013-1023, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33566716
18.
Evaluating the diagnostic and prognostic value of biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy.
Eur Heart J Qual Care Clin Outcomes
; 7(6): 564-573, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32687175
19.
A 58-Year-Old Man With Episodic Hypercapnic Respiratory Failure.
Chest
; 160(2): e185-e188, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34366042
20.
Pharmacodynamic Properties of Subcutaneous Immunoglobulin in Myasthenia Gravis: Sub-analyses From an Open-Label Trial.
Front Neurol
; 11: 921, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32982936